TRIALSPARK
TrialSpark is a technology-driven pharma company that runs end-to-end clinical trials, focused on bringing new treatments to patients faster and more efficiently. TrialSpark has built a technology platform that optimizes all aspects of a clinical trial, enabling more efficient trial design, faster trial completion, and higher trial data quality. TrialSpark in-licenses and co-develops drug programs through in-house development, joint ventures, and NewCos.
TRIALSPARK
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2014-06-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.trialspark.com
Total Employee:
101+
Status:
Active
Total Funding:
156 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager WordPress Content Delivery Network Domain Not Resolving Wordpress Plugins
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Employees Featured
Founder
Investors List
ArrowMark Partners
ArrowMark Partners investment in Series C - TrialSpark
John Doerr
John Doerr investment in Series C - TrialSpark
Felicis Ventures
Felicis Ventures investment in Series C - TrialSpark
Dragoneer Investment Group
Dragoneer Investment Group investment in Series C - TrialSpark
Casdin Capital
Casdin Capital investment in Series C - TrialSpark
Sam Altman
Sam Altman investment in Series C - TrialSpark
Spark Capital
Spark Capital investment in Series C - TrialSpark
Thrive Capital
Thrive Capital investment in Series C - TrialSpark
Lachy Groom
Lachy Groom investment in Series C - TrialSpark
Sequoia Capital
Sequoia Capital investment in Series C - TrialSpark
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-30 | January | TrialSpark investment in Series A - January | 10 M USD |
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-08 | TrialSpark hires two new executives to join the company's leadership team, Gavin Corcoran, MD (Chief Medical Officer) and James Leslie, MBA (Chief Financial Officer) |
Official Site Inspections
http://www.trialspark.com Semrush global rank: 2.97 M Semrush visits lastest month: 5.49 K
- Host name: ec2-54-146-249-230.compute-1.amazonaws.com
- IP address: 54.146.249.230
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "TrialSpark"
TrialSpark - Formation Bio
Our approach to drug development. Formation Bio acquires clinical-stage drugs from pharma, universities, and biotech and develops them faster and more efficiently by leveraging our …See details»
Immigrant Ben Liu And TrialSpark Revolutionizing Clinical Trials
Aug 10, 2022 Ben Liu, an immigrant from Taiwan, is cofounder and CEO of TrialSpark. ... Today, in most cases, a pharmaceutical company hires a contract research organization …See details»
undefined | Introducing Formation Bio
Dec 5, 2023 Our early years - and the TrialSpark name - were focused on sparking innovation within clinical trials, building clinical trial technology tools for drug developers, including …See details»
Trialspark: Empowering professionals with autonomy
Jul 25, 2024 Empowering professionals with autonomy “An organization will only be as great as the people you partner with,” says Benjamine Liu, CEO & Co-Founder, TrialSpark – a …See details»
TrialSpark Rebrands as Formation Bio, Continuing Its Commitment …
NEW YORK, Dec. 5, 2023 /PRNewswire/ -- TrialSpark, a tech-driven drug developer with its own portfolio of clinical stage drug assets, is rebranding to Formation Bio. The new name is a …See details»
Mission and Purpose at TrialSpark | by Benjamine Liu - Medium
Nov 14, 2018 The Journey Ahead at TrialSpark We are excited to share that TrialSpark has raised a $156M Series C to support our mission to bring new treatments to patients faster …See details»
TrialSpark Rebrands as Formation Bio, Continuing Its Commitment …
Dec 5, 2023 TrialSpark was founded in 2016 with the goal of creating this generation's tech-driven pharma company differentiated by radically more efficient clinical trials. Before acquiring …See details»
TrialSpark Rebrands as Formation Bio, Continuing Its ... - BioSpace
Dec 5, 2023 TrialSpark was founded in 2016 with the goal of creating this generation’s tech-driven pharma company differentiated by radically more efficient clinical trials. Before acquiring …See details»
TrialSpark Rebrands as Formation Bio, Continuing Its Commitment …
Dec 5, 2023 TrialSpark, a tech-driven drug developer with its portfolio of clinical-stage drug assets, is rebranding to Formation Bio. The new name is a reflection of the company's …See details»
The Journey Ahead at TrialSpark - Medium
Sep 30, 2021 We are excited to share that TrialSpark has raised a $156M Series C to support our mission to bring new treatments to patients faster and…See details»
Startup With $120 Million for Deals Aims to Make Drugs Cheaply
Sep 30, 2021 New York-based TrialSpark Inc. will fund its move into drug development with a $156 million financing round that closed earlier this year and values the company at more than …See details»
TrialSpark - Medium
TrialSpark’s mission is to bring new treatments to patients faster and more efficiently, and that presents a unique set of challenges that… Chris Ryan Dec 7, 2018See details»
Working at TrialSpark - Great Place To Work®
TrialSpark has built a technology platform that optimizes all aspects of drug development, enabling more efficient trial design, faster trial completion, and higher trial data quality. …See details»
TrialSpark raises $156MM Series C Funding led by Sam ... - PR …
Sep 30, 2021 TrialSpark raises $156MM Series C Funding led by Sam Altman and Lachy Groom - Technology-driven pharma company that runs faster and cheaper clinical trials will …See details»
TrialSpark Company Profile, Stock Price, News, Rankings - Fortune
Best Small and Medium Workplaces in Biotechnology and Pharmaceuticals 2023 Employees say: "I feel so inspired every day to come to a company that has its mission—to bring new …See details»
TrialSpark Rebrands as Formation Bio, Continuing Its Commitment …
NEW YORK, Dec. 5, 2023 /PRNewswire/ -- TrialSpark, a tech-driven drug developer with its own portfolio of clinical stage drug assets, is rebranding to Formation Bio. The new name is a …See details»
TrialSpark announces partnership with major pharmaceutical …
Oct 4, 2022 TrialSpark has built a technology platform that optimizes all aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial …See details»
Tech-driven clinical trial startup TrialSpark lands $156M in Series C
Oct 1, 2021 TrialSpark, a health tech platform that lets providers become clinical trial sites, scored a whopping $156 million as part of a Series C funding round to start developing its own …See details»
Sanofi inks deal with TrialSpark to find, license new drugs
Oct 6, 2022 Sanofi has inked a partnership with clinical study tech company TrialSpark in an effort to leverage novel methods to help identify and bring new drugs to market.. The two …See details»
TrialSpark and Sanofi announce collaboration to accelerate COPD ...
NEW YORK, May 26, 2021 /PRNewswire/ -- TrialSpark Inc., a tech-enabled drug development company dedicated to improving the speed, quality, and innovation of clinical trials, announced …See details»